TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NP90323(a) Botulinum Toxin Type A Medicines (Botox®)

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP90323(a) Botulinum Toxin Type A Medicines (Botox®)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
5.2Bids / Report
10.8% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 512 active published awards; 455 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Nov 2023, 09:12 GMT
Last source update17 Nov 2023, 09:12 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-0407c3
What is being bought
Supply of Botulinum Toxin Type A Medicines(Botox®) to NHS Scotland: NP90323(a): Botulinum Toxin Type A Injection 50-unit vial/ Botulinum Toxin Type A Injection 100-unit vial/ Botulinum Toxin Type A Injection 200-unit vial (Botox®)
What changed
From the official release history
  1. Official notice release published
    17 Nov 2023, 09:12 GMT
  2. Status changed to complete
    4 Oct 2023, 11:19 BST
  3. Official notice release published
    4 Oct 2023, 11:19 BST
  4. Buyer information updated
    4 Oct 2023, 11:19 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Framework Agreement is for the supply of Botulinum Toxin Type A (Botox®) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Nov 2023, 09:12 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 24 Oct 2023, 00:00 BST · £8,051,564
Commercial outcome and competition
Awards
AbbVie Ltd
Not published · Not published · active
Contracts
Contract
£8,051,564 · signed 24 Oct 2023, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
electronicBids: 1 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 1 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authority GB-FTS-91922
View buyer profile

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
    buyer
    centralPurchasingBody

    Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    Michelle.semple3@nhs.scot

  • AbbVie Ltd
    supplier

    Abbvie House, Vanwall Business Park, Maidenhead, UKM, SL6 4UB
    carol.woodland@abbvie.com
    +44 1628561090

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk
    +44 1312252525
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.